Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kurek, Krzysztof ^a   Łukaszuk, Bartłomiej ^a   Piotrowska, Dominika M ^a   Wiesiołek, Patrycja ^a   Chabowska, Anna Małgorzata ^b   Zendzian Piotrowska, Małgorzata ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Blood Transfusion Center   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE GLUCOSYLTRANSFERASE; CYCLOOXYGENASE 2; GALACTOSYLCERAMIDE; GANGLIOSIDE; GLUCOSYLCERAMIDE; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; COLITIS; COLORECTAL CANCER; DAIRY PRODUCT; DIETARY INTAKE; DIGESTIVE SYSTEM INFLAMMATION; ENTERITIS; EPITHELIUM CELL; FAMILIAL COLON POLYPOSIS; FRUIT; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; HELICOBACTER INFECTION; HUMAN; LIVER CANCER; NONHUMAN; PLANT; REVIEW; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; STOMACH DISEASE; UPREGULATION; ANIMAL; CHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; METABOLIC NETWORKS AND PATHWAYS; SPHINGOLIPIDS;

EID: 84884864563     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/908907     Document Type: Review

References (97)

1. Thudichum J. L. W., The Chemical Constitution of the Brain 1884
2. Duan R.-D., Nilsson Å., Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Progress in Lipid Research 2009 48 1 62 72 2-s2.0-57649188727 10.1016/j.plipres.2008.04.003
3. Kurek K., Piotrowska D. M., Wiesiołek P., Chabowski A., Zendzian-Piotrowska M., Role of sphingolipids in digestive system. Postȩpy Higieny i Medycyny Doświadczalnej 2012 66 868 875 10.5604/17322693.1019650
4. Nilsson Å., Duan R.-D., Absorption and lipoprotein transport of sphingomyelin. Journal of Lipid Research 2006 47 1 154 171 2-s2.0-30844463225 10.1194/jlr.M500357-JLR200 (Pubitemid 43107459)
5. Danielsen E. M., Hansen G. H., Lipid raft organization and function in brush borders of epithelial cells. Molecular Membrane Biology 2006 23 1 71 79 2-s2.0-33645311204 10.1080/09687860500445604
6. Olaisson H., Mårdh S., Arvidson G., Phospholipid organization in H,K-ATPase-containing membranes from pig gastric mucosa. Journal of Biological Chemistry 1985 260 20 11262 11267 2-s2.0-0022180531 (Pubitemid 16253292)
7. Breimer M. E., Distribution of molecular species of sphingomyelins in different parts of bovine digestive tract. Journal of Lipid Research 1975 16 3 189 194 2-s2.0-0016741937
8. Natomi H., Sugano K., Takaku F., Iwamori M., Glycosphingolipid composition of the gastric mucosa. A role of sulfatides in gastrointestinal mucosal defense? Journal of Clinical Gastroenterology 1990 12 supplement 1 S52 S57 2-s2.0-0025042368 (Pubitemid 20301135)
9. Hanada K., Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochimica et Biophysica Acta 2003 1632 1-3 16 30 2-s2.0-0037680229 10.1016/S1388-1981(03)00059-3 (Pubitemid 36628112)
10. Futerman A. H., Riezman H., The ins and outs of sphingolipid synthesis. Trends in Cell Biology 2005 15 6 312 318 2-s2.0-20444363393 10.1016/j.tcb.2005. 04.006 (Pubitemid 40805327)
11. Kitatani K., Idkowiak-Baldys J., Hannun Y. A., The sphingolipid salvage pathway in ceramide metabolism and signaling. Cellular Signalling 2008 20 6 1010 1018 2-s2.0-42249105215 10.1016/j.cellsig.2007.12.006
12. Hannun Y. A., Obeid L. M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews Molecular Cell Biology 2008 9 2 139 150 2-s2.0-38549152194 10.1038/nrm2329 (Pubitemid 351158911)
13. Merrill A. H. Jr., Nixon D. W., Williams R. D., Activities of serine palmitoyltransferase (3-ketosphinganine synthase) in microsomes from different rat tissues. Journal of Lipid Research 1985 26 5 617 622 2-s2.0-0021814377 (Pubitemid 15073734)
14. Duan R.-D., Hertervig E., Nyberg L., Hauge T., Sternby B., Lillienau J., Farooqi A., Nilsson A., Distribution of alkaline sphingomyelinase activity in human beings and animals: tissue and species differences. Digestive Diseases and Sciences 1996 41 9 1801 1806 2-s2.0-0029744263 (Pubitemid 26319756)
15. Duan R.-D., Alkaline sphingomyelinase: an old enzyme with novel implications. Biochimica et Biophysica Acta 2006 1761 3 281 291 2-s2.0-33646146401 10.1016/j.bbalip.2006.03.007
16. Duan R.-D., Cheng Y., Hansen G., Hertervig E., Liu J.-J., Syk I., Sjöström H., Nilsson Å., Purification, localization, and expression of human intestinal alkaline sphingomyelinase. Journal of Lipid Research 2003 44 6 1241 1250 2-s2.0-0141428125 10.1194/jlr.M300037-JLR200 (Pubitemid 37279643)
17. Nyberg L., Farooqi A., Bläckberg L., Duan R.-D., Nilsson Å., Hernell O., Digestion of ceramide by human milk bile salt-stimulated lipase. Journal of Pediatric Gastroenterology and Nutrition 1998 27 5 560 567 2-s2.0-0031785063 10.1097/00005176-199811000-00013 (Pubitemid 28492257)
18. El Bawab S., Roddy P., Qian T., Bielawska A., Lemasters J. J., Hannun Y. A., Molecular cloning and characterization of a human mitochondrial ceramidase. Journal of Biological Chemistry 2000 275 28 21508 21513 2-s2.0-0034647935 10.1074/jbc.M002522200 (Pubitemid 30481855)
19. Duan R.-D., Bergman T., Xu N., Wu J., Cheng Y., Duan J., Nelander S., Palmberg C., Nilsson Å., Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. Journal of Biological Chemistry 2003 278 40 38528 38536 2-s2.0-0141532169 10.1074/jbc.M305437200 (Pubitemid 37221748)
20. Kono M., Dreier J. L., Ellis J. M., Allende M. L., Kalkofen D. N., Sanders K. M., Bielawski J., Bielawska A., Hannun Y. A., Proia R. L., Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. Journal of Biological Chemistry 2006 281 11 7324 7331 2-s2.0-33646154333 10.1074/jbc.M508382200 (Pubitemid 43847501)
21. Kirby R. J., Zheng S., Tso P., Howles P. N., Hui D. Y., Bile salt-stimulated carboxyl ester lipase influences lipoprotein assembly and secretion in intestine: a process mediated via ceramide hydrolysis. Journal of Biological Chemistry 2002 277 6 4104 4109 2-s2.0-0037040172 10.1074/jbc. M107549200 (Pubitemid 34968668)
22. Liu F., Cheng Y., Wu J., Tauschel H.-D., Duan R.-D., Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Letters 2006 235 1 141 146 2-s2.0-33646156070 10.1016/j.canlet.2005.04.016
23. Fukuda Y., Kihara A., Igarashi Y., Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochemical and Biophysical Research Communications 2003 309 1 155 160 2-s2.0-0041734874 10.1016/S0006-291X(03)01551-1 (Pubitemid 36999771)
24. Sugiura M., Kono K., Liu H., Shimizugawa T., Minekura H., Spiegel S., Kohama T., Ceramide kinase, a novel lipid kinase: molecular cloning and functional characterization. Journal of Biological Chemistry 2002 277 26 23294 23300 2-s2.0-0037189475 10.1074/jbc.M201535200 (Pubitemid 34952158)
25. Nilsson A., Hertervig E., Duan R.-D., Szuhaj B. F., van Nieuwenhuyzen W., Digestion and absorption of sphingolipids in food. Nutrition and Biochemistry of Phospholipids 2003 Champaign, Ill, USA AOCS Press 70 79
26. Duan R.-D., Sphingomyelin hydrolysis in the gut and clinical implications in colorectal tumorigenesis and other gastrointestinal diseases. Scandinavian Journal of Gastroenterology 1998 33 7 673 683 2-s2.0-0031825658 10.1080/00365529850171594 (Pubitemid 28358049)
27. Wang B., Petocz P., Miller J. B., Relationship of sialic acid and fatty acid composition of brain gangliosides: breast-fed vs formula-fed infant. Asia Pacific Journal of Clinical Nutrition 2003 12 supplement S43
28. Zeisel S. H., Char D., Sheard N. F., Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas. Journal of Nutrition 1986 116 1 50 58 2-s2.0-0022629488 (Pubitemid 16212055)
29. Zeisel S. H., Mar M.-H., Howe J. C., Holden J. M., Concentrations of choline-containing compounds and betaine in common foods. Journal of Nutrition 2003 133 5 1302 1307 (Pubitemid 36548698)
30. Zeisel S. H., Mar M.-H., Howe J. C., Holden J. M., Erratum: concentrations of choline-containing compounds and betaine in common foods. Journal of Nutrition 2003 133 9 2918 2919 2-s2.0-0042920599
31. Rueda R., Maldonado J., Narbona E., Gil A., Neonatal dietary gangliosides. Early Human Development 1998 53 supplement 1 S135 S147 2-s2.0-0031737096 10.1016/S0378-3782(98)00071-1 (Pubitemid 28548708)
32. Sugawara T., Kinoshita M., Ohnishi M., Nagata J., Saito M., Digestion of maize sphingolipids in rats and uptake of sphingadienine by Caco-2 cells. Journal of Nutrition 2003 133 9 2777 2782 2-s2.0-0042419991 (Pubitemid 37099759)
33. Blank M. L., Cress E. A., Smith Z. L., Snyder F., Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids. Journal of Nutrition 1992 122 8 1656 1661 2-s2.0-0026725338
34. Nyberg L., Nilsson Å., Lundgren P., Duan R.-D., Localization and capacity of sphingomyelin digestion in the rat intestinal tract. Journal of Nutritional Biochemistry 1997 8 3 112 118 2-s2.0-0030964872 10.1016/S0955- 2863(97)00010-7 (Pubitemid 27239995)
35. Ohlsson L., Hertervig E., Jönsson B. A. G., Duan R.-D., Nyberg L., Svernlöv R., Nilsson Å., Sphingolipids in human ileostomy content after meals containing milk sphingomyelin. American Journal of Clinical Nutrition 2010 91 3 672 678 2-s2.0-77749279629 10.3945/ajcn.2009.28311
36. Duan R.-D., Physiological functions and clinical implications of sphingolipids in the gut. Journal of Digestive Diseases 2011 12 2 60 70 2-s2.0-79952684482 10.1111/j.1751-2980.2011.00481.x
37. Lafont F., van Nhieu G. T., Hanada K., Sansonetti P., van der Goot F. G., Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction. EMBO Journal 2002 21 17 4449 4457 2-s2.0-0037009369 10.1093/emboj/cdf457 (Pubitemid 34984332)
38. Svennerholm L., Interaction of cholera toxin and ganglioside G(M1). Advances in Experimental Medicine and Biology 1976 71 191 204 2-s2.0-0016911427
39. Lindner J., Geczy A. F., Russell-Jones G. J., Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB. Scandinavian Journal of Immunology 1994 40 5 564 572 2-s2.0-0027998099 10.1111/j.1365-3083.1994.tb03505. x (Pubitemid 24334025)
40. Rolsma M. D., Kuhlenschmidt T. B., Gelberg H. B., Kuhlenschmidt M. S., Structure and function of a ganglioside receptor for porcine rotavirus. Journal of Virology 1998 72 11 9079 9091 2-s2.0-0031657985 (Pubitemid 28471852)
41. Lanne B., Uggla L., Stenhagen G., Karlsson K. A., Enhanced binding of enterotoxigenic escherichia coli K99 to amide derivatives of the receptor ganglioside NeuGc-GM3. Biochemistry 1995 34 6 1845 1850 2-s2.0-0028918834
42. Birecki C. J., Drozdowski L. A., Suh M., Eek J. P., Clandinin M. T., Thomson A. B. R., Dietary gangliosides enhance in vitro lipid uptake in weanling rats. Journal of Pediatric Gastroenterology and Nutrition 2006 42 1 59 65 2-s2.0-30344485706 10.1097/01.mpg.0000187567.79633.a7 (Pubitemid 43061011)
43. Rueda R., The role of dietary gangliosides on immunity and the prevention of infection. British Journal of Nutrition 2007 98 supplement 1 S68 S73 2-s2.0-35148878616 10.1017/S0007114507832946 (Pubitemid 47543481)
44. Idota T., Kawakami H., Murakami Y., Sugawara M., Inhibition of cholera toxin by human milk fractions and sialyllactose. Bioscience, Biotechnology, and Biochemistry 1995 59 3 417 419 2-s2.0-0029263399
45. Suh M., Belosevic M., Clandinin M. T., Dietary lipids containing gangliosides reduce Giardia muris infection in vivo and survival of Giardia lamblia trophozoites in vitro. Parasitology 2004 128 part 6 595 602 2-s2.0-2942731875 10.1017/S0031182004005128 (Pubitemid 38789270)
46. Sprong R. C., Hulstein M. F. E., van der Meer R., Bactericidal activities of milk lipids. Antimicrobial Agents and Chemotherapy 2001 45 4 1298 1301 2-s2.0-0035082206 10.1128/AAC.45.4.1298-1301.2001 (Pubitemid 32231016)
47. Gulbins E., Dreschers S., Wilker B., Grassmé H., Ceramide, membrane rafts and infections. Journal of Molecular Medicine 2004 82 6 357 363 2-s2.0-3042757722 10.1007/s00109-004-0539-y (Pubitemid 38887865)
48. Hait N. C., Oskeritzian C. A., Paugh S. W., Milstien S., Spiegel S., Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochimica et Biophysica Acta 2006 1758 12 2016 2026 2-s2.0-33845291120 10.1016/j.bbamem.2006.08.007 (Pubitemid 44879368)
49. Kihara A., Mitsutake S., Mizutani Y., Igarashi Y., Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Progress in Lipid Research 2007 46 2 126 144 2-s2.0-34247520569 10.1016/j.plipres.2007.03.001 (Pubitemid 46661866)
50. Futerman A. H., Hannun Y. A., The complex life of simple sphingolipids. EMBO Reports 2004 5 8 777 782 2-s2.0-4444309565 10.1038/sj.embor.7400208 (Pubitemid 39199166)
51. Nyberg L., Duan R.-D., Nilsson Å., A mutual inhibitory effect on absorption of sphingomyelin and cholesterol. Journal of Nutritional Biochemistry 2000 11 5 244 249 2-s2.0-0034039623 10.1016/S0955-2863(00)00069-3 (Pubitemid 30392408)
52. Non S. K., Koo S. I., Milk sphingomyelin is more effective than egg sphingomyelin in inhibiting intestinal absorption of cholesterol and fat in rats. Journal of Nutrition 2004 134 10 2611 2616 2-s2.0-4744352141 (Pubitemid 39315261)
53. Eckhardt E. R. M., Wang D. Q. H., Donovan J. M., Carey M. C., Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology 2002 122 4 948 956 2-s2.0-0036202294 (Pubitemid 34267278)
54. Feng D., Ohlsson L., Ling W., Nilsson Å., Duan R.-D., Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in caco-2 cells. Digestive Diseases and Sciences 2010 55 12 3377 3383 2-s2.0-78649327270 10.1007/s10620-010-1202-9
55. Garmy N., Taïeb N., Yahi N., Fantini J., Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. Journal of Lipid Research 2005 46 1 36 45 2-s2.0-11244300911 10.1194/jlr.M400199-JLR200 (Pubitemid 40066669)
56. Ogretmen B., Hannun Y. A., Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Reviews Cancer 2004 4 8 604 616 2-s2.0-3543114272 (Pubitemid 39025055)
57. Liu Y.-Y., Han T.-Y., Giuliano A. E., Cabot M. C., Ceramide glycosylation potentiates cellular multidrug resistance. FASEB Journal 2001 15 3 719 730 2-s2.0-0035079539 10.1096/fj.00-0223com (Pubitemid 32245990)
58. Zalatan J. G., Fenn T. D., Brunger A. T., Herschlag D., Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry 2006 45 32 9788 9803 2-s2.0-33747517236 10.1021/bi060847t (Pubitemid 44257425)
59. Dudeja P. K., Dahiya R., Brasitus T. A., The role of sphingomyelin synthetase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat colonic plasma membranes. Biochimica et Biophysica Acta 1986 863 2 309 312 2-s2.0-0022839146 (Pubitemid 17219342)
60. Dillehay D. L., Webb S. K., Schmelz E.-M., Merrill A. H. Jr., Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. Journal of Nutrition 1994 124 5 615 620 2-s2.0-0028304788 (Pubitemid 24157280)
61. Selzner M., Bielawska A., Morse M. A., Rüdiger H. A., Sindram D., Hannun Y. A., Clavien P.-A., Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Research 2001 61 3 1233 1240 2-s2.0-0035114217 (Pubitemid 32174448)
62. Sjöqvist U., Hertervig E., Nilsson A., Duan R. D., Ost A., Tribukait B., Löfberg R., Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflammatory Bowel Diseases 2002 8 4 258 263 10.1097/00054725-200207000-00004 (Pubitemid 34784978)
63. Hertervig E., Nilsson A., Nyberg L., Duan R. D., Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 1997 79 3 448 453 (Pubitemid 27051767)
64. Hertervig E., Nilsson Å., Björk J., Hultkrantz R., Duan R.-D., Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation? British Journal of Cancer 1999 81 2 232 236 2-s2.0-0032857215 10.1038/sj.bjc.6690682 (Pubitemid 29423700)
65. di Marzio L., di Leo A., Cinque B., Fanini D., Agnifili A., Berloco P., Linsalata M., Lorusso D., Barone M., de Simone C., Cifone M. G., Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 2005 14 4 856 862 2-s2.0-20144386965 10.1158/1055-9965.EPI-04-0434 (Pubitemid 40478548)
66. Wu J., Cheng Y., Nilsson Å., Duan R.-D., Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis 2004 25 8 1327 1333 2-s2.0-4344656249 10.1093/carcin/ bgh140 (Pubitemid 39162699)
67. Shida D., Kitayama J., Yamaguchi H., Okaji Y., Tsuno N. H., Watanabe T., Takuwa Y., Nagawa H., Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Research 2003 63 7 1706 1711 2-s2.0-0037379768 (Pubitemid 36373664)
68. van Brooklyn J. R., Jackson C. A., Pearl D. K., Kotur M. S., Snyder P. J., Prior T. W., Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. Journal of Neuropathology and Experimental Neurology 2005 64 8 695 705 2-s2.0-23844498431 (Pubitemid 41177111)
69. Kawamori T., Kaneshiro T., Okumura M., Maalouf S., Uflacker A., Bielawski J., Hannun Y. A., Obeid L. M., Role for sphingosine kinase 1 in colon carcinogenesis. FASEB Journal 2009 23 2 405 414 2-s2.0-59649086217 10.1096/fj.08-117572
70. Müller R., Berliner C., Leptin J., Pörtner D., Bialecki W., Kleuser B., Schumacher U., Milićević N. M., Expressionof sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells. Tumor Biology 2010 31 4 341 349 10.1007/s13277-010-0043-7
71. Visentin B., Vekich J. A., Sibbald B. J., Cavalli A. L., Moreno K. M., Matteo R. G., Garland W. A., Lu Y., Yu S., Hall H. S., Kundra V., Mills G. B., Sabbadini R. A., Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 2006 9 3 225 238 2-s2.0-33644830810 10.1016/j.ccr.2006.02.023 (Pubitemid 43357948)
72. Ikeda M., Kihara A., Igarashi Y., Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol. Biochemical and Biophysical Research Communications 2004 325 1 338 343 2-s2.0-7444239039 10.1016/j.bbrc.2004.10.036 (Pubitemid 39441198)
73. Oskouian B., Soonyakumaran P., Borowsky A. D., Crans A., Dillard-Telm L., Tam Y. Y., Bandhuvula P., Saba J. D., Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proceedings of the National Academy of Sciences of the United States of America 2006 103 46 17384 17389 2-s2.0-33751225686 10.1073/pnas.0600050103 (Pubitemid 44788978)
74. Kohno M., Momoi M., Oo M. L., Paik J.-H., Lee Y.-M., Venkataraman K., Ai Y., Ristimaki A. P., Fyrst H., Sano H., Rosenberg D., Saba J. D., Proia R. L., Hla T., Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Molecular and Cellular Biology 2006 26 19 7211 7223 2-s2.0-33749185077 10.1128/MCB.02341-05 (Pubitemid 44477697)
75. Bouhet S., Hourcade E., Loiseau N., Fikry A., Martinez S., Roselli M., Galtier P., Mengheri E., Oswald I. P., The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells. Toxicological Sciences 2004 77 1 165 171 2-s2.0-1642422766 10.1093/toxsci/kfh006 (Pubitemid 38128657)
76. Bock J., Liebisch G., Schweimer J., Schmitz G., Rogler G., Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. World Journal of Gastroenterology 2007 13 39 5217 5225 2-s2.0-34948885187 (Pubitemid 47527738)
77. Furuya H., Ohkawara S., Nagashima K., Asanuma N., Hino T., Dietary sphingomyelin alleviates experimental inflammatory bowel disease in mice. International Journal for Vitamin and Nutrition Research 2008 78 1 41 48 2-s2.0-48749099833 10.1024/0300-9831.78.1.41
78. Ronet C., Darche S., de Moraes M. L., Miyake S., Yamamura T., Louis J. A., Kasper L. H., Buzoni-Gatel D., NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. Journal of Immunology 2005 175 2 899 908 2-s2.0-23244434262 (Pubitemid 41094973)
79. Takeuchi K., Smale S., Premchand P., Maiden L., Sherwood R., Thjodleifsson B., Bjornsson E., Bjarnason I., Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2006 4 2 196 202 2-s2.0-32044465242 10.1016/S1542-3565(05)00980-8 (Pubitemid 43199690)
80. Maines L. W., Fitzpatrick L. R., French K. J., Zhuang Y., Xia Z., Keller S. N., Upson J. J., Smith C. D., Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Digestive Diseases and Sciences 2008 53 4 997 1012 2-s2.0-40849134419 10.1007/s10620-007-0133-6
81. Gómez-Muñoz A., Kong J. Y., Parhar K., Shih W. W., Gangoiti P., González M., Eivemark S., Salh B., Duronio V., Steinbrecher U. P., Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Letters 2005 579 17 3744 3750 2-s2.0-21244479753 10.1016/j.febslet.2005.05.067 (Pubitemid 40897719)
82. Subramanian P., Stahelin R. V., Szulc Z., Bielawska A., Cho W., Chalfant C. E., Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 α and enhances the interaction of the enzyme with phosphatidylcholine. Journal of Biological Chemistry 2005 280 18 17601 17607 2-s2.0-20444371635 10.1074/jbc.M414173200 (Pubitemid 41388994)
83. Chalfant C. E., Spiegel S., Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. Journal of Cell Science 2005 118 part 20 4605 4612 2-s2.0-27844517355 10.1242/jcs.02637 (Pubitemid 41646371)
84. Keranen A., Gangliosides of the human gastrointestinal mucosa. Biochimica et Biophysica Acta 1975 409 3 320 328 2-s2.0-0016716474
85. Dohi T., Ohta S., Hanai N., Yamaguchi K., Oshima M., Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. Journal of Biological Chemistry 1990 265 14 7880 7885 2-s2.0-0025343822
86. Ångström J., Teneberg S., Milh M. A., Larsson T., Leonardsson I., Olsson B.-M., Halvarsson M. Ö., Danielsson D., Näslund I., Ljungh Å., Wadström T., Karlsson K.-A., The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 1998 8 4 297 309 2-s2.0-0041988992 10.1093/glycob/8.4.297 (Pubitemid 28186629)
87. Gupta V. R., Patel H. K., Kostolansky S. S., Ballivian R. A., Eichberg J., Blanke S. R., Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA. PLoS Pathogens 2008 4 5 2-s2.0-44949199208 10.1371/journal.ppat. 1000073 e1000073 (Pubitemid 351811520)
88. Hata Y., Kita T., Murakami M., Bovine milk inhibits both adhesion of Helicobacter pylori to sulfatide and Helicobacter pylori-induced vacuolation of vero cells. Digestive Diseases and Sciences 1999 44 8 1696 1702 2-s2.0-0032857205 10.1023/A:1026699902328 (Pubitemid 29434747)
89. Wada A., Hasegawa M., Wong P.-F., Shirai E., Shirai N., Tan L.-J., Llanes R., Hojo H., Yamasaki E., Ichinose A., Ichinose Y., Senba M., Direct binding of gangliosides to Helicobacter pylori vacuolating cytotoxin (VacA) neutralizes its toxin activity. Glycobiology 2010 20 6 668 678 2-s2.0-77952823782 10.1093/glycob/cwq014
90. Lin Y.-L., Liu J.-S., Chen K.-T., Chen C.-T., Chan E.-C., Identification of neutral and acidic sphingomyelinases in Helicobacter pylori. FEBS Letters 1998 423 2 249 253 2-s2.0-0006512778 10.1016/S0014-5793(98)00087-8 (Pubitemid 28343218)
91. Cheng Y., Wu J., Hertervig E., Lindgren S., Duan D., Nilsson Å., Duan R.-D., Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis. British Journal of Cancer 2007 97 10 1441 1448 2-s2.0-36148953306 10.1038/sj.bjc.6604013 (Pubitemid 350114779)
92. Gelderblom W. C. A., Kriek N. P. J., Marasas W. F. O., Thiel P. G., Toxicity and carcinogenicity of the Fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis 1991 12 7 1247 1251 2-s2.0-0025878789
93. Ueno Y., Iijima K., Wang S.-D., Sugiura Y., Sekijima M., Tanaka T., Chen C., Yu S.-Z., Fumonisins as a possible contributory risk factor for primary liver cancer: a 3-year study of corn harvested in Haimen, China, by HPLC and ELISA. Food and Chemical Toxicology 1997 35 12 1143 1150 2-s2.0-0031464955 10.1016/S0278-6915(97)00113-0 (Pubitemid 28021662)
94. Yoshizawa T., Yamashita A., Luo Y., Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Applied and Environmental Microbiology 1994 60 5 1626 1629 2-s2.0-0028269321 (Pubitemid 24144824)
95. Tatsumi T., Takehara T., Yamaguchi S., Sasakawa A., Sakamori R., Ohkawa K., Kohga K., Uemura A., Hayashi N., Intrahepatic delivery of α -galactosylceramide-pulsed dendritic cells suppresses liver tumor. Hepatology 2007 45 1 22 30 2-s2.0-33846413504 10.1002/hep.21447 (Pubitemid 46144361)
96. Zigmond E., Preston S., Pappo O., Lalazar G., Margalit M., Shalev Z., Zolotarov L., Friedman D., Alper R., Ilan Y., β -glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders. Gut 2007 56 1 82 89 2-s2.0-33846008441 10.1136/gut.2006.095497 (Pubitemid 46044892)
97. 3 sensitizes human hepatoma cells to cancer therapy. Journal of Biological Chemistry 2002 277 49870 49876 10.1074/jbc.M208303200 (Pubitemid 36014435)